Trial intelligence / Profile preview

Human fibrinogen in congenital fibrinogen deficiency (CTR20130074)

CTR20130074Phase 3Active

Sponsor
Shandong Taibang Biological Products
Start
Jun 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital hypofibrinogenemia, sponsored by Shandong Taibang Biological Products. Started Jun 2013; status: active.

02

Drugs

Fibrinogen human
03

Conditions

fibrinogen deficiencycongenital hypofibrinogenemia

Beyond the preview

Go deeper on CTR20130074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call